September was Prostate Cancer Awareness Month, a time to shed light on the significance of early detection and research in combating this prevalent disease. In this exclusive interview, we dive into the ongoing prostate cancer research of Chloe Liu, a dedicated fourth-year PhD candidate, working in the labs of Drs. Maxime Bouchard and Luke McCaffrey at the Rosalind and Morris Goodman Cancer Research Centre (GCI).
Prostate cancer is a formidable adversary, ranking among the most common cancers in men and carrying the potential for grave consequences when not caught in its early stages. Chloe Liu's research mission is clear: to enhance early detection by scrutinizing Prostatic Intraepithelial Neoplasia (PIN), a precursor to prostate cancer.
"Understanding the cellular intricacies and medical implications of PIN is critical," Chloe explains. "Our goal is to unveil the features within precursor cells that act as triggers for the development of aggressive prostate cancers. By doing so, we hope to detect aggressive prostate cancer at an earlier juncture, allowing for prompt and personalized treatment plans."
Chloe's research is not undertaken in isolation. It is made feasible through fruitful collaborations with various research facilities and centers, including the Advanced BioImaging Facility, Single Cell Imaging, and Mass Cytometry Analysis Platform at GCI, Ï㽶ÊÓƵ Health Centre, CHU de Québec-Université Laval Research Center, and McGill Genome Centre. This collaborative synergy harnesses expertise and resources across multiple domains, fostering an environment conducive to groundbreaking discoveries.
If you wish to learn more about Chloe's work or engage in a dialogue, feel free to reach out to her at chloe.liu [at] mail.mcgill.ca.Ìý